Statistics

Total Visits

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial45

Select a period of time:

Number of views in the range

Views
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial27

Views

Views
October 20242
November 20241
December 20241
January 20254
February 20253
March 202516
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States12
United Kingdom1
 

Top cities views

Views
Elk Grove Village1